Issue of Equity following Interest Conversion
Neoterra Group Plc has announced that its lender, Catalyse Capital Limited, will convert £20,000 of accrued interest into 2,000,000 new ordinary shares at a price of 1 penny per share. This conversion, related to a £500,000 loan facility, will result in no cash outflow for the company. Following the expected admission of these new shares to the London Stock Exchange around October 28, 2026, Neoterra's total issued share capital will increase to 459,666,113 ordinary shares.
Select text to share a quote on X · sign in to keep highlights & notes in your TERA notes
NeoTerra Group Plc (LSE: TERA) (OTCQB: ANRCF), the African critical minerals exploration and development company, announces that it has received notice from its lender, Catalyse Capital Limited ("CCL"), of CCL's election to convert interest due on the Company's loan facility into new ordinary shares, in accordance with the terms of the facility, as amended.
Conversion of Interest into Equity
Interest of £20,000 accrued at a rate of 12% per annum on the £500,000 loan for the period from 1 July 2026 to 30 October 2026 (being the original maturity date of the facility, prior to its extension to 30 October 2027, as announced on 23 September 2026) will be settled through the issue of 2,000,000 new ordinary shares of £0.01 each in the Company (the "Interest Shares") at a price of 1 penny per Interest Share. No cash will be paid by the Company in respect of the interest converted.
Admission and Total Voting Rights
The Interest Shares are being issued pursuant to the authorities granted to the Directors at the annual general meeting of the Company held on 26 November 2025 and will rank pari passu in all respects with the Company's existing ordinary shares.
Application will be made for the 2,000,000 Interest Shares to be admitted to trading on the Main Market of the London Stock Exchange ("Admission"), which is expected to take place on or around 28 October 2026. Following Admission, the Company's enlarged issued share capital and total voting rights will comprise 459,666,113 ordinary shares. The Company has no shares held in treasury. This figure of 459,666,113 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
To subscribe for RNS alerts, please visit: https://neoterra-group.com/announcements
NeoTerra Group Plc
Cédric Simonet, CEO +44 (0) 7769 555 757 (Cedric.Simonet@neoterra-group.com)
Louise Adrian, CFO +44 (0) 7721 492 922 (Louise.Adrian@neoterra-group.com)
Strand Hanson (Financial Adviser) +44 (0) 20 7409 3494
Christopher Raggett
Imogen Ellis
Zeus Capital (Corporate Broker) +44 (0) 20 3829 5000
Simon Johnson
James Hornigold
- 13.6Mt at 2.42% TREO
- 3.48Mt at 20.6% CaF2
- 11.73Mt at 54.7g/t Ga2O3
The project is held under a 25-year mining licence and has received US Government support in the form of a US$1.875 million grant from USTDA to advance the rare earths component through the prefeasibility stage.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.